Oracle Health Sciences Enterprise Healthcare Analytics suite and Oracle Healthcare Master Person Index – along with Oracle Fusion Middleware components and Oracle Database 11g have been selected by
Hamamatsu Photonics claims that its new product provides high resolution, high sensitivity and high speed imaging for advanced applications. The camera contains back-thinned EMCCD with Peak Quantum Efficiency
The OX51 project aims to develop a sublingual dosage form for the treatment of acute intensive pain episodes in relation to care-related diagnostic or therapeutic procedures for patients
The licensed technology relates to the discoveries that miR-33a and miR-33b down-regulate target genes involved in cholesterol transport and genes related to metabolic syndrome. Additionally, Regulus also controls
Nile intends to develop Cenderitide as an outpatient therapy to be delivered to acutely decompensated heart failure (ADHF) patients continuously for up to 90 days after discharge from
Oracle claims Health Sciences LabPas helps to manage the workflow and offer real-time access to data. ICON is a provider of outsourced development services to the pharmaceutical, biotechnology
The company has posted net income of $13.1m, an increase of 42%, as compared to the net income of $9.2m for the year ago period. Gross profit was
Multikine is CEL-SCI’s immunotherapy which was developed as a standard of care in treating head and neck cancer. The Phase III trial is designed to determine if Multikine
BioSante Pharma said that LibiGel is a testosterone gel in Phase III clinical development for the treatment of women who suffer from female sexual dysfunction (FSD). The efficacy
Zalicus said that the US patent no. 7,915,265 entitled ‘Combinations for the Treatment of Immunoinflammatory Disorders’ offers coverage for Synavive through August 2025. Synavive is indicated for the
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.